Induction of anti-tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccine

Journal of Gene Medicine

Volumn 2, Issue 2, 2000, Pages 135-140

  White, Stephen A ^a   LoBuglio, Albert F ^a   Arani, Ramin B ^a   Pike, Mary J ^a   Moore, Susan E ^a   Barlow, Daunte L ^a   Conry, Robert M ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Carcinoembryonic antigen; DNA vaccine; Immune response; Immunization; Intrasplenic

Indexed keywords

CYTOMEGALOVIRUS;

CARCINOEMBRYONIC ANTIGEN; DNA VACCINE;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; C57BL MOUSE; CELL CULTURE; COLON TUMOR; CYTOMEGALOVIRUS; FEMALE; GENE TRANSFER; GENE VECTOR; GENETICS; IMMUNOLOGY; INJECTION; MOUSE; PROMOTER REGION; SPLEEN;

ANIMALS; ANTIBODY FORMATION; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; CYTOMEGALOVIRUS; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INJECTIONS; MICE; MICE, INBRED C57BL; PROMOTER REGIONS (GENETICS); SPLEEN; TUMOR CELLS, CULTURED; VACCINES, DNA;

EID: 0034155243     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-2254(200003/04)2:2<135::AID-JGM88>3.0.CO;2-O     Document Type: Article

References (26)

1. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745-1749.
2. Torres CA, Iwasaki A, Barber BH, Robinson HL. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol 1997; 158: 4529-4532.
3. Ertl HCJ, Xiang ZQ. Genetic immunization. Viral Immunol 1996; 9: 1-9.
4. Corr M, Lee DJ, Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 1996; 184: 1555-1560.
5. Iwasaki A, Torres CA, Ohashi PS, Robinson HL The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 1997; 159: 11-14.
6. Winegar RA, Monforte JA, Suing KD, O'Loughlin KG, Rudd CJ, Macgregor JT. Determination of tissue distribution of an intramuscular plasmid vaccine using PCR and in situ DNA hybridization. Hum Gene Ther 1996; 7: 2185-2194.
7. Noll A, Bucheler N, Bohn E, Schirmbeck R, Reimann J, Autenrieth IB. DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria. Eur J Immunol 1999; 29: 986-996.
8. Chattergoon MA, Robinson TM, Boyer JD, Weiner DB. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J Immunol 1998; 160: 5707-5718.
9. Robinson HL, Torres CA. DNA vaccines. Semin Immunol 1997; 9: 271-283.
10. Gerloni M, Ballou WR, Billetta ZM. Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization. Natl Biotechnol 1997; 15: 876-881.
11. Conry RM, LoBuglio AF, Loechel F, Moore SE, Sumerel LA, Barlow DL, Pike MJ, Curiel DT. A carcinoembryonic antigen polynucleotide vaccine for human clinical use. Gene Ther 1995; 2: 33-38.
12. Fox BA, Spiess PJ, Kasid A, Puri R, Mule JJ, Weber JS, Rosenberg SA. In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes. A Biol Resp Mod 1990; 9: 499-511.
13. Robbins PF, Kantor JA, Salgaller M. Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line. Cancer Res 1991; 51: 3657-3662.
14. Irvine KR, Chamberlain RS, Shulman EP, Rosenberg SA, Restifo NR. Route of immunization and the therapeutic impact of recombinant anticancer vaccines. J Natl Cancer Inst 1997; 89: 390-392.
15. Hurpin C, Rotarioa C, Bisceglia H, Chevalier M, Tartaglia J, Erdile L. The mode of presentation and route of administration are critical for the induction of immune responses to p53 and antitumor immunity. Vaccine 1998; 16: 208-215.
16. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunizations by parenteral, mucosal, and gene gun inoculations. Proc Natl Acad Sci USA 1993; 90: 11478-11482.
17. Bohm W, Mertens T, Schirmbeck R, Reimann J. Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses. Vaccine 1998; 16: 949-954.
18. Smith BF, Baker HJ, Curiel DT, Jiang W, Conry RM. Humoral and cellular immune responses of dogs immunized with a nucleic acid vaccine encoding human carcinoembryonic antigen. Gene Ther 1998; 5: 865-868.
19. Lew D, Parker SE, Latimer T, Abai AM, Kuwahara-Rundell A, Doh SG, Yang ZY, Laface D, Gromkowski SH, Nabel GJ, Manthorpe M, Norman J. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Hum Gene Ther 1995; 6: 553-564.
20. Cohen AD, Boyer JD, Weiner DB. Modulating the immune response to genetic immunization. FASEB J 1998; 2: 1611-1626.
21. Pertmer TM, Roberts TR, Haynes JR. Influenza virus nucleo-protein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol 1996; 70: 6119-6125.
22. Feltquate DM, Heaney S, Webster RG, Robinson HL. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunizations. J Immunol 1997; 158: 2278-2284.
23. Conry RM, LoBuglio AF, Curiel DT. Polynucleotide-mediated immunization therapy of cancer. Semin Oncol 1996; 23: 135-147.
24. Torres CA, Iwasaki A, Barber BH, Robinson HL. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol 1997; 158: 4529-4532.
25. Corr M, Lee DJ, Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 1996; 184: 1555-1560.
26. Iwasaki A, Torres AT, Ohashi PS, Robinson HL, Barber BH. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 1997; 159: 11-14.